Mullen Automotive Secures Major European Order for Delivery EVs
- New European Purchase Order: Mullen Automotive secures a purchase order for 40 Mullen-GO urban delivery vehicles from Antidoto SA in Switzerland.
- Order Details: The initial purchase order is valued at $0.44 million, with plans for more orders in the future.
- Expansion Plans: Antidoto SA intends to order a minimum of 180 units for 2025 and will initially deploy 40 vehicles in Switzerland.
- Collaboration Benefits: Antidoto SA believes that collaborating with Mullen could enhance their production capacity by offering electric vehicles to customers.
- Stock Update: Mullen Automotive's stock has decreased significantly over the past year, but investors can access it through specific ETFs.
Trade with 70% Backtested Accuracy
Analyst Views on VXF
About the author


Stock Price Reaction: Shares of Assertio Holdings, Inc. (ASRT) fell 1.5% after the announcement of an agreement to be acquired by Garda Therapeutics for $125.1 million in cash.
Acquisition Details: Under the deal, Garda will pay Assertio shareholders $18 per share in cash, which represents a 3% discount to the stock's closing price on Tuesday.
Transaction Timeline: The acquisition is expected to close in the second quarter of 2026, subject to customary closing conditions.
Further Updates: Investors can follow updates on this developing story directly on Stocktwits.

Company Restructuring: Mawson Infrastructure Group's shares surged over 60% following the announcement of a significant overhaul of its board of directors, including the appointment of a new executive leadership team.
Investor Agreement: The changes come after a cooperation agreement with activist investor Endeavor, which had built a substantial stake in the company, leading to a restructuring aimed at stabilizing governance and focusing on core operations.
Stock Performance: Mawson's stock rose 63% to a two-month high, making it one of the top gainers in the market, with retail sentiment described as "extremely bullish" regarding the company's future.
Cautious Optimism: While some investors express optimism about the new board's potential for long-term value creation, others remain cautious, questioning whether the leadership transition will lead to meaningful operational improvements.

Chegg Inc. Share Surge: Chegg Inc. (CHGG) shares increased nearly 16% following a letter from significant shareholder Galloway Capital Partners, which highlighted a disconnect between the company's market price and its intrinsic value.
Financial Health Assessment: Galloway Capital stated that Chegg maintains a strong balance sheet, expects to end the year with net cash and no debt, and sees no credible risk of financial distress.
Market Mispricing Concerns: The letter expressed concerns that the market is incorrectly pricing Chegg as if it is in financial distress, despite the company's solid financial standing.
Retail Sentiment: At the time of writing, retail sentiment around Chegg was trending in a bullish territory, indicating positive investor outlook.
Stock Performance: Artelo Biosciences (ARTL) shares increased by over 21% in pre-market trading following the company's announcement of regaining compliance with Nasdaq's listing requirements.
Compliance Confirmation: The company received a letter from Nasdaq confirming its compliance with the exchange's rules, including a minimum equity requirement of $2.5 million and the necessity for an annual shareholders' meeting.
Monitoring Requirement: Artelo will be subject to a mandatory panel monitor for one year as part of the compliance process with Nasdaq's listing rules.
Market Sentiment: Retail sentiment around Artelo Biosciences was noted to be in a "bearish" territory at the time of the report.
Stock Surge: Bullfrog AI Holdings Inc. (BFRG) shares rose over 114% in pre-market trading following the announcement of a deal with a major global pharmaceutical company.
Strategic Agreement: The agreement requires Bullfrog AI to utilize its bfLEAP program to identify and prioritize novel drug targets for major depressive disorder (MDD).
Development Goals: The company aims to accelerate its drug discovery and clinical development programs through this partnership.
Market Sentiment: Retail sentiment around Bullfrog AI is currently described as "extremely bullish," with high message volumes noted at the time of reporting.

Stock Performance: Roma Green Finance shares surged over 10% in pre-market trading following the announcement of a $100 million share repurchase program.
Program Details: The share repurchase program, authorized by the company's board of directors, will remain effective until December 31, 2028.
Market Sentiment: Retail sentiment around Roma Green Finance is currently bullish, with message volumes reported at high levels.
Further Updates: Investors can receive updates on this developing story directly from Stocktwits.





